NEW YORK (GenomeWeb News) – CombiMatrix today reported that its third-quarter revenues increased 5 percent as the firm continued to shift its focus to prenatal testing.

The Irvine, Calif.-based molecular diagnostics firm reported total revenues of $1.3 million for the three months ended Sept. 30, compared to $1.2 million for the third quarter of 2011.

It brought in $1.1 million from diagnostic services during the quarter, down from $1.2 million the previous year. The quarter included $195,000 in clinical trials support through a program with Affymetrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.